Prostate cancer decisions — 2025

The Board granted service connection for prostate cancer, on a direct basis, resolving reasonable doubt in the Veteran's favor due to evidence of ionized radiation exposure during service.

The Board remands the claim for service connection for prostate cancer to schedule a VA examination that considers all potential toxic exposures and relevant literature submitted by the Veteran.

The Board granted service connection for prostate cancer and erectile dysfunction, as secondary to the service-connected prostate cancer.

The appeal for service connection for the residuals of prostate cancer was dismissed as it has been granted. The claims for earlier effective dates, TDIU, and initial ratings were denied.

The Board remands the issue of entitlement to service connection for prostate cancer due to a need for a medical opinion in compliance with the Sergeant First Class Heath Robinson Honoring our Promise to Address Comprehensive Toxins Act of 2022 (PACT Act).

The Board granted service connection for prostate cancer based on the Veteran's exposure to herbicide agents during his service in Thailand, which is presumed due to the PACT Act.

The Board denied service connection for prostate cancer and diabetes mellitus, type II as there was no evidence of in-service exposure to herbicide agents or asbestos, and the conditions did not manifest during service or within one year of discharge.

The appeal is remanded to obtain an addendum medical opinion regarding the Veteran's prostate cancer residuals and their relation to renal dysfunction.

The Board granted service connection for prostate cancer and obstructive sleep apnea, but remanded the claims for lumbar spondylosis and right knee arthritis due to a duty to assist error.

The Board remands the claim for service connection of residuals of prostate cancer status post radical prostatectomy to ensure an adequate examination and opinion are provided.

The Board remands the Veteran's claims for service connection for small bowel cancer, lung cancer, prostate cancer, and skin cancer to correct a pre-decisional duty-to-assist error related to VA's statutory duties under the Sergeant First Class Heath Robinson Honoring our Promise to Address Comprehensive Toxics Act of 2022 (PACT Act).

The veteran's appeals for extensions of time to file Board Appeal requests were denied, and the attempted appeals were dismissed.

The Board granted a 40 percent disability rating for residuals of prostate cancer, effective May 1, 2025.

The Board remands the claims for service connection for macular degeneration and prostate cancer to correct a pre-decisional duty to assist error related to toxic exposure risk activity.

The Board remands the claim for service connection for prostate cancer to obtain a medical opinion regarding its etiology, as new and relevant evidence has been submitted.

The Board remands the claim for service connection for prostate cancer, status post radical prostatectomy with residuals and erectile dysfunction due to an inadequate medical opinion regarding the etiology of the condition.

The Board granted service connection for prostate cancer, finding that the Veteran's in-service benzene exposure caused his condition.

The Board granted service connection for prostate cancer as secondary to a now-service-connected anorectal/perianal region condition, but remanded the claim for BPH due to an inadequate VA opinion.

The Board granted service connection for prostate cancer, but remanded the claims for type II diabetes mellitus, coronary artery disease, hypertension, and peripheral neuropathy of the bilateral upper extremities.

The Board granted service connection for prostate cancer based on the presumption of service connection for certain diseases associated with exposure to burn pits and other toxins. The claim for hypertension was remanded due to an inadequate etiology opinion.